UA100552C2 - Применение гетероциклических бензопроизводных сульфамида для лечения тревожных расстройств - Google Patents

Применение гетероциклических бензопроизводных сульфамида для лечения тревожных расстройств

Info

Publication number
UA100552C2
UA100552C2 UAA201012664A UAA201012664A UA100552C2 UA 100552 C2 UA100552 C2 UA 100552C2 UA A201012664 A UAA201012664 A UA A201012664A UA A201012664 A UAA201012664 A UA A201012664A UA 100552 C2 UA100552 C2 UA 100552C2
Authority
UA
Ukraine
Prior art keywords
anxiety
treatment
related disorders
benzo
fused heterocycle
Prior art date
Application number
UAA201012664A
Other languages
English (en)
Ukrainian (uk)
Inventor
Вирджиния Л. Смит-Свинтоски
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of UA100552C2 publication Critical patent/UA100552C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Данное изобретение представляет собой способ лечения тревожного расстройства и родственных патологических расстройств, который включает введение субъекту, который в этом нуждается, терапевтически эффективных количеств одного или больше новых гетероциклических бензопроизводных сульфамида формулы (I)и формулы (II).Данное изобретение направлено на создание способа лечения тревожного расстройства и родственных патологических расстройств, который включает монотерапию и, как вариант, комбинированную терапию по крайней мере одним анксиолитиком.
UAA201012664A 2008-03-26 2008-03-26 Применение гетероциклических бензопроизводных сульфамида для лечения тревожных расстройств UA100552C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/058210 WO2009120189A1 (en) 2008-03-26 2008-03-26 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of anxiety

Publications (1)

Publication Number Publication Date
UA100552C2 true UA100552C2 (ru) 2013-01-10

Family

ID=39926425

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201012664A UA100552C2 (ru) 2008-03-26 2008-03-26 Применение гетероциклических бензопроизводных сульфамида для лечения тревожных расстройств

Country Status (8)

Country Link
EP (1) EP2276481B1 (ru)
KR (1) KR101511574B1 (ru)
AU (1) AU2008353489B2 (ru)
BR (1) BRPI0822385A2 (ru)
EA (1) EA019544B1 (ru)
ES (1) ES2517598T3 (ru)
UA (1) UA100552C2 (ru)
WO (1) WO2009120189A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7662271B2 (en) * 2005-12-21 2010-02-16 Chevron U.S.A. Inc. Lubricating oil with high oxidation stability
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US20070155824A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis

Also Published As

Publication number Publication date
EA201071119A1 (ru) 2011-06-30
EP2276481B1 (en) 2014-07-30
AU2008353489A1 (en) 2009-10-01
BRPI0822385A2 (pt) 2019-09-24
KR101511574B1 (ko) 2015-04-15
EP2276481A1 (en) 2011-01-26
AU2008353489B2 (en) 2014-11-27
WO2009120189A1 (en) 2009-10-01
ES2517598T3 (es) 2014-11-03
KR20100134052A (ko) 2010-12-22
EA019544B1 (ru) 2014-04-30

Similar Documents

Publication Publication Date Title
HK1141231A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
HK1125040A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
MX2010002732A (es) Inhibidores de f1f0-atpasa y metodos relacionados.
IL192181A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
EA201290041A1 (ru) Лечение расстройств, связанных с макрофагами
MX350761B (es) Inhibidores de isoindolinona de fosfatidilinositol 3-cinasa.
ES2721448T3 (es) GLYX-13 para uso en el tratamiento de enfermedad de Alzheimer, enfermedad de Parkinson y enfermedad de Huntington
MX2010007490A (es) Preparacion de derivados de sulfamida.
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
IL192100A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
MX2009013353A (es) Compuestos activadores de telomerasa y metodos para su uso.
TW200738651A (en) Cyclohexyl sulfonamide derivatives
MY143269A (en) Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
WO2010123527A3 (en) Use of epidermal growth factor inhibitors in the treatment of viral infection
MX2009004770A (es) Compuestos de carbamato para usarse en el tratamiento de la depresion.
WO2007095609A3 (en) Use of benzo-heteroaryl sulfamide derivatives for the treatment of mania and bipolar disorder
WO2007095611A3 (en) Use of benzo-fused heteroaryl sulfamide derivatives for the treatment of migraine
UA100552C2 (ru) Применение гетероциклических бензопроизводных сульфамида для лечения тревожных расстройств
MX2009010164A (es) Metodo para tratar dolor mediado por el receptor cb2.
MX2013011561A (es) Compuestos de benzodioxepina y benzodioxina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
JO2608B1 (en) Use of different sulfamide derivatives combined with benzo ring to treat depression
ATE468852T1 (de) Lofexidine zur intraspinalen anwendung
UA95094C2 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для лечения маниакального синдрома и биполярного расстройства
TW200738231A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine